A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review: ...

Many people who take GLP-1 drugs find that their cravings disappear. I went to a Buddhist monastery to understand why that ...

JAKARTA, Indonesia and NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- (LeaderMed), a global pharmaceutical development company, and Combiphar, a leading Indonesian pharmaceutical company in Southeast ...

“As consumers are becoming more health conscious, this could lead to a potential decrease in consumption of confectionery,” ...

I highlight potential of Biomea Fusion's diabetes drug amid competition, advises caution with stock due to risks. Read more ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...

全球减重神药瘦瘦针“类升糖素胜肽-1”（GLP-1）发明人、丹麦哥本哈根大学教授霍斯特（Jens Juul ...

If you’ve been trying to reach a healthier weight, you may be considering semaglutide medications like Ozempic and Wegovy.

周一，美国美敦力公司（NYSE:RMD）获得了瑞穗证券的积极展望，该公司将其股票目标价从此前的230美元上调至250美元，同时维持"跑赢大市"评级。这一调整是在anticipation of ResMed的分析师日活动之前做出的，该活动定于今天在纽约证券交易所举行，从美国东部时间中午12点开始。 预计公司将在活动中涵盖一系列主题，包括Samsung Galaxy和苹果iOS设备等可穿戴诊断技术的优 ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...